295 related articles for article (PubMed ID: 24374978)
1. A novel SERPINE1-FOSB fusion gene results in transcriptional up-regulation of FOSB in pseudomyogenic haemangioendothelioma.
Walther C; Tayebwa J; Lilljebjörn H; Magnusson L; Nilsson J; von Steyern FV; Øra I; Domanski HA; Fioretos T; Nord KH; Fletcher CD; Mertens F
J Pathol; 2014 Apr; 232(5):534-40. PubMed ID: 24374978
[TBL] [Abstract][Full Text] [Related]
2. Penile pseudomyogenic hemangioendothelioma/epithelioid sarcoma-like hemangioendothelioma with a novel pattern of SERPINE1-FOSB fusion detected by RT-PCR--report of a case.
Ide YH; Tsukamoto Y; Ito T; Watanabe T; Nakagawa N; Haneda T; Nagai M; Yamanishi K; Hirota S
Pathol Res Pract; 2015 May; 211(5):415-20. PubMed ID: 25749627
[TBL] [Abstract][Full Text] [Related]
3. Expanding the Spectrum of Genetic Alterations in Pseudomyogenic Hemangioendothelioma With Recurrent Novel ACTB-FOSB Gene Fusions.
Agaram NP; Zhang L; Cotzia P; Antonescu CR
Am J Surg Pathol; 2018 Dec; 42(12):1653-1661. PubMed ID: 30256258
[TBL] [Abstract][Full Text] [Related]
4. ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features.
Antonescu CR; Chen HW; Zhang L; Sung YS; Panicek D; Agaram NP; Dickson BC; Krausz T; Fletcher CD
Genes Chromosomes Cancer; 2014 Nov; 53(11):951-9. PubMed ID: 25043949
[TBL] [Abstract][Full Text] [Related]
5. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
[TBL] [Abstract][Full Text] [Related]
7. A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone.
Bridge JA; Sumegi J; Royce T; Baker M; Linos K
Genes Chromosomes Cancer; 2021 Jan; 60(1):38-42. PubMed ID: 32749039
[TBL] [Abstract][Full Text] [Related]
8. Integrated multimodal genetic testing of Ewing sarcoma--a single-institution experience.
Warren M; Weindel M; Ringrose J; Venable C; Reyes A; Terashima K; Rao P; Chintagumpala M; Hicks MJ; Lopez-Terrada D; Lu XY
Hum Pathol; 2013 Oct; 44(10):2010-9. PubMed ID: 23706910
[TBL] [Abstract][Full Text] [Related]
9. Fusion of the Genes
Panagopoulos I; Lobmaier I; Gorunova L; Heim S
Cancer Genomics Proteomics; 2019; 16(4):293-298. PubMed ID: 31243110
[TBL] [Abstract][Full Text] [Related]
10. Telatinib Is an Effective Targeted Therapy for Pseudomyogenic Hemangioendothelioma.
van IJzendoorn DGP; Sleijfer S; Gelderblom H; Eskens FALM; van Leenders GJLH; Szuhai K; Bovée JVMG
Clin Cancer Res; 2018 Jun; 24(11):2678-2687. PubMed ID: 29511030
[No Abstract] [Full Text] [Related]
11. Cutaneous pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma FOSB immunohistochemistry demonstrating the SERPINE1-FOSB fusion gene.
Alegría-Landa V; Santonja C; Jo-Velasco M; Kutzner H; Requena L
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):e550-e552. PubMed ID: 28622428
[No Abstract] [Full Text] [Related]
12. Translocation t(7;19)(q22;q13)−a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?
Trombetta D; Magnusson L; von Steyern FV; Hornick JL; Fletcher CD; Mertens F
Cancer Genet; 2011 Apr; 204(4):211-5. PubMed ID: 21536240
[TBL] [Abstract][Full Text] [Related]
13. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.
Jin Y; Möller E; Nord KH; Mandahl N; Von Steyern FV; Domanski HA; Mariño-Enríquez A; Magnusson L; Nilsson J; Sciot R; Fletcher CD; Debiec-Rychter M; Mertens F
Genes Chromosomes Cancer; 2012 May; 51(5):510-20. PubMed ID: 22337624
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
15. A novel SERPINE1-FOSB fusion gene in pseudomyogenic hemangioendothelioma results in activation of intact FOSB and the PI3K-AKT-mTOR signaling pathway and responsiveness to sirolimus.
Ren J; Wang X; Zhou Y; Yue X; Chen S; Ding X; Zeng S; Jiang X; Liu X; Guo Q
J Dermatol; 2021 Dec; 48(12):1900-1906. PubMed ID: 34580903
[TBL] [Abstract][Full Text] [Related]
16. Vascular Tumor Recapitulated in Endothelial Cells from hiPSCs Engineered to Express the
van IJzendoorn DGP; Salvatori DCF; Cao X; van den Hil F; Briaire-de Bruijn IH; de Jong D; Mei H; Mummery CL; Szuhai K; Bovée JVMG; Orlova VV
Cell Rep Med; 2020 Dec; 1(9):100153. PubMed ID: 33377124
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
18. Pseudomyogenic hemangioendothelioma of skin, bone and soft tissue-a clinicopathological, immunohistochemical, and fluorescence in situ hybridization study.
Pradhan D; Schoedel K; McGough RL; Ranganathan S; Rao UNM
Hum Pathol; 2018 Jan; 71():126-134. PubMed ID: 29104110
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma].
Kekeeva TV; Riazantseva AA; Zavalishina LÉ; Andreeva IuIu; Babenko OV; Zaletaev DV; Frank GA
Mol Biol (Mosk); 2011; 45(5):840-4. PubMed ID: 22393780
[TBL] [Abstract][Full Text] [Related]
20. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
